Evaluate the Efficacy and Safety of KK8398 in Patients With AchondroplasiaAOBA Study
Status:
RECRUITING
Trial end date:
2031-05-31
Target enrollment:
Participant gender:
Summary
This trial will evaluate the efficacy of KK8398 on annualized height velocity after 52 weeks of repeated administration of KK8398 to patients with achondroplasia